Background: A twin pregnancy consisting of a complete hydatidiform mole and a coexisting normal fetus (CMCF) is a rare and challenging condition when diagnosed prenatally and is associated with major obstetric complications. Case Report: We present a case of CMCF in which the molar component presented as a major placenta praevia at 19 weeks, and which was complicated by a placental abscess with maternal septicaemia from 26 weeks. An emergency caesarean section, performed at 28 weeks’ gestation due to severe maternal septicaemia, resulted in the delivery of a live male infant. Despite the molar mass being praevia, the delivery was not complicated by extensive haemorrhage. Conclusion: This is only the second case of CMCF complicated by a molar praevia and the first complicated by a placental abscess. We believe that the 2 conditions are linked and that the absence of normal fetal membranes surrounding the molar mass enabled secondary colonization by vaginal bacteria. Therefore, we recommend that immediate antibiotic treatment is initiated in cases of CMCF presenting as a praevia when maternal and/or fetal symptoms of infection develop.
© 2009 S. Karger AG, Basel
Article / Publication Details
Published online: 10/27/2009
Number of Print Pages: 4
Number of Figures: 1
Number of Tables: 0
ISSN: 1015-3837 (Print)
eISSN: 1421-9964 (Online)
For additional information: http://www.karger.com/FDT
Copyright / Drug Dosage
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher or, in the case of photocopying, direct payment of a specified fee to the Copyright Clearance Center.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in goverment regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.